Aesthetic Microneedles: From Nanochips To Dissolvable – Technological Iteration And Compliance Trends in Mesotherapy

Aesthetic Microneedles: From "Nanochips" to "Dissolvable" – Technological Iteration and Compliance Trends in Mesotherapy

Core Product Terms: Derma Roller, Nanochip, Dissolving Microneedle Patch

Representative Manufacturers: Nateron Biotech (纳晶®), Raphas, YOUWE Biotech, Qinglan Bio (青澜生物)

Aesthetic microneedles represent the most mature commercialization of microneedle technology, evolving through three generations: from "mechanical rollers" to "nanochips," and now to "dissolvable microneedle patches." The core logic is the pursuit of "less pain, greater efficacy, and more at-home convenience."

I. History of Technological Iteration

* First Generation: Derma Rollers: Metal needles that physically create micro-channels by rolling on the skin to promote collagen regeneration. Significant drawbacks: painful, high infection risk, requires professional operation.

* Second Generation: Nanochips: Represented by Nateron Biotech (纳晶®). Utilizes single-crystal silicon nanotechnology with needle tip diameters under 80nm, penetrating only the stratum corneum without reaching nerves, achieving "painless delivery." Its core value lies in increasing the transdermal absorption rate of functional skincare products (e.g., growth factors, hyaluronic acid) by dozens of times.

* Third Generation: Dissolvable Microneedle Patches: The current mainstream trend. Represented by YOUWE Biotech and Qinglan Bio, these use biodegradable materials like hyaluronic acid, loaded with whitening or anti-aging ingredients. The needles dissolve upon skin insertion, eliminating sharps waste and perfectly suiting at-home care scenarios.

II. Manufacturer Landscape: Technologists vs. Capacity Leaders

* Technologists: Raphas (South Korea) focuses on high-value-added ingredients combined with microneedles, such as its "microneedle + peptide" solutions enhancing transdermal efficiency of large-molecule peptides. Nateron Biotech builds a closed loop of "device + consumables," where its nanochip device requires proprietary serums.

* Capacity Leaders: Qinglan Bio and YOUWE Biotech's core strength lies in large-scale manufacturing. Qinglan has a fully automated production line in Shenzhen with a monthly capacity of 4 million patches, primarily providing ODM services for international brands. YOUWE boasts an annual capacity of 50+ million pieces, exporting to over 30 countries.

III. Compliance Challenges: Device or Cosmetic?

The regulatory boundary for aesthetic microneedles is blurry. Nanochip-type products are usually regulated as Class II medical devices (as penetration-enhancing devices). Dissolvable microneedle patches claiming medical effects like "wrinkle reduction" or "filling" may be classified as Class III devices (like implantable threads). If marketed solely as skincare delivery vehicles, they may be registered as cosmetics. Amendments to the "Regulations for the Supervision and Administration of Medical Devices" implemented in 2025 have tightened oversight on "device-registered" microneedles, cracking down on non-compliant aesthetic studios and creating market space for GMP-certified (e.g., YOUWE Biotech) legitimate manufacturers.

IV. Future Trend: Personalized Customization

Future aesthetic microneedles will evolve towards "skin-type customization." Through AI skin analysis, personalized microneedle array density and formulations (e.g., salicylic acid patches for acne-prone skin, repair patches for sensitive skin) can be generated and delivered directly to consumers via DTC models.